Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hearne Michael S
Relationship:   Chief Financial Officer
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   2,620    

Indirect Shares

   12,767,435      
Direct Value   $7,465,690    

Indirect Value

   $36,380,806,033      
Total Shares   12,770,055      
Total Value   $36,388,271,723      


Odonate Therapeutics Inc $7,465,690 Odonate Therapeutics Inc $7,465,690
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    20   
    3    

     Stock price went up :
    10   
    0    
     Stock price went down :
    10   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
   -17.1%
 -97.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Odonate Therapeutics Inc ODT Chief Financial Officer 2021-03-15 2,620 2021-11-19 12,767,435    Premium*  
            La Jolla Pharmaceutical Co LJPC Chief Financial Officer 2022-08-22 0 2022-08-22 0    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-09-08 4 B $3.90 $328,529 I/I 84,152 9,278,825 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-09-09 4 B $4.01 $509,940 I/I 126,665 9,405,490 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-09-15 4 A $13.06 $562 D/D 43 1,833 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-09-28 4 B $13.06 $1,305,710 I/I 100,000 15,227,900 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-09-29 4 B $13.85 $150,698 I/I 10,882 15,238,782 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-09-30 4 A $11.42 $571 D/D 50 1,883 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-10-15 4 A $13.35 $561 D/D 42 1,925 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-10-15 4 A $3.32 $561 D/D 169 169 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-10-30 4 A $12.25 $564 D/D 46 1,971 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-10-30 4 A $2.89 $566 D/D 196 365 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-11-13 4 A $12.20 $561 D/D 46 2,017 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-11-13 4 A $3.98 $561 D/D 141 506 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-11-30 4 A $4.23 $566 D/D 134 640 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-11-30 4 A $12.77 $575 D/D 45 2,062 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-12-15 4 A $3.83 $562 D/D 147 787 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-15 4 A $12.91 $555 D/D 43 2,105 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-21 4 B $14.58 $905,767 I/I 62,144 15,300,926 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-22 4 B $14.58 $1,107,587 I/I 74,502 15,375,428 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-23 4 B $15.43 $2,167,853 I/I 139,138 15,514,566 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-12-31 4 A $3.30 $564 D/D 171 958 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2020-12-31 4 A $16.32 $5,712 D/D 350 2,455 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-12-31 4/A A $3.30 $5,435 D/D 1,648 2,435 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-01-15 4 A $4.55 $618 D/D 136 1,094 0 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2021-01-15 4 A $16.99 $595 D/D 35 2,490 0 -
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-01-15 4/A A $4.55 $618 D/D 136 2,571 0 -
  145  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us